RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Cartesian Therapeutics Stock

Cartesian Therapeutics ROCE 2024

Cartesian Therapeutics ROCE

0.61

Ticker

RNAC

ISIN

US8162121045

WKN

A2AML0

In 2024, Cartesian Therapeutics's return on capital employed (ROCE) was 0.61, a 296.2% increase from the 0.15 ROCE in the previous year.

Cartesian Therapeutics Aktienanalyse

What does Cartesian Therapeutics do?

Cartesian Therapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROCE Details

Unraveling Cartesian Therapeutics's Return on Capital Employed (ROCE)

Cartesian Therapeutics's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Cartesian Therapeutics's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Cartesian Therapeutics's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Cartesian Therapeutics’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Cartesian Therapeutics stock

What is the ROCE (Return on Capital Employed) of Cartesian Therapeutics this year?

The ROCE of Cartesian Therapeutics is 0.61 undefined this year.

How has the ROCE (Return on Capital Employed) of Cartesian Therapeutics developed compared to the previous year?

The ROCE of Cartesian Therapeutics has increased by 296.2% increased compared to the previous year.

What does a high ROCE (Return on Capital Employed) mean for investors of Cartesian Therapeutics?

A high Return on Capital Employed (ROCE) indicates that Cartesian Therapeutics has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.

What does a low ROCE (Return on Capital Employed) mean for investors of Cartesian Therapeutics?

A low ROCE (Return on Capital Employed) can indicate that Cartesian Therapeutics has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.

How does an increase in ROCE from Cartesian Therapeutics impact the company?

An increase in the ROCE of Cartesian Therapeutics can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.

How does a reduction in the ROCE of Cartesian Therapeutics affect the company?

A decrease in ROCE of Cartesian Therapeutics can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.

What are some factors that can influence the ROCE of Cartesian Therapeutics?

Some factors that can affect Cartesian Therapeutics's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.

Why is the ROCE of Cartesian Therapeutics so important for investors?

The ROCE of Cartesian Therapeutics is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.

What strategic measures can Cartesian Therapeutics take to improve the ROCE?

To improve the ROCE, Cartesian Therapeutics can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.

How much dividend does Cartesian Therapeutics pay?

Over the past 12 months, Cartesian Therapeutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Cartesian Therapeutics is expected to pay a dividend of 0 USD.

What is the dividend yield of Cartesian Therapeutics?

The current dividend yield of Cartesian Therapeutics is .

When does Cartesian Therapeutics pay dividends?

Cartesian Therapeutics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Cartesian Therapeutics?

Cartesian Therapeutics paid dividends every year for the past 0 years.

What is the dividend of Cartesian Therapeutics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Cartesian Therapeutics located?

Cartesian Therapeutics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Cartesian Therapeutics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Cartesian Therapeutics from 11/4/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/4/2024.

When did Cartesian Therapeutics pay the last dividend?

The last dividend was paid out on 11/4/2024.

What was the dividend of Cartesian Therapeutics in the year 2023?

In the year 2023, Cartesian Therapeutics distributed 0 USD as dividends.

In which currency does Cartesian Therapeutics pay out the dividend?

The dividends of Cartesian Therapeutics are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Cartesian Therapeutics stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Cartesian Therapeutics

Our stock analysis for Cartesian Therapeutics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Cartesian Therapeutics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.